| Net Loss Per Share |
Basic and diluted net loss per share attributable to common stockholders is calculated as follows (in thousands except share and per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders |
|
$ |
(27,482 |
) |
|
$ |
(19,908 |
) |
|
$ |
(50,541 |
) |
|
$ |
(44,947 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
37,686,002 |
|
|
|
37,428,365 |
|
|
|
37,657,251 |
|
|
|
37,408,084 |
|
Less: Weighted-average unvested shares of common stock |
|
|
(27,752 |
) |
|
|
(271,386 |
) |
|
|
(37,366 |
) |
|
|
(319,701 |
) |
Weighted-average common shares outstanding—basic and diluted |
|
|
37,658,250 |
|
|
|
37,156,979 |
|
|
|
37,619,885 |
|
|
|
37,088,383 |
|
Net loss per share attributable to common stockholders—basic and diluted |
|
$ |
(0.73 |
) |
|
$ |
(0.54 |
) |
|
$ |
(1.34 |
) |
|
$ |
(1.21 |
) |
The following outstanding potentially dilutive securities have been excluded from the calculation of diluted net loss per share, as their effect would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
Three and Six Months Ended June 30, |
|
|
|
2026 |
|
|
2025 |
|
Options to purchase common stock |
|
|
4,348,978 |
|
|
|
4,388,377 |
|
Restricted stock units |
|
|
2,265,153 |
|
|
|
232,304 |
|
Restricted stock subject to future vesting |
|
|
13,852 |
|
|
|
684,744 |
|
Employee stock purchase plan |
|
|
136,308 |
|
|
|
— |
|
Total |
|
|
6,764,291 |
|
|
|
5,305,425 |
|
|